Automated keratometry gives better results than Scheimpflug keratometry

September 12, 2011

Article

Conventional automated keratometry is better at measuring refractive outcomes after cataract surgery than pupil-based Scheimpflug keratometry.

Conventional automated keratometry is better at measuring refractive outcomes after cataract surgery than pupil-based Scheimpflug keratometry, according to a study published in the Journal of Cataract and Refractive Surgery.

Dr Sheridan Lam et al., DuPage Ophthalmology, Lombard, Illinois, USA, conducted a comparative case series on 110 eyes of 76 virgin cornea patients (Group 1) and 137 eyes of 94 control group participants also with virgin corneas (Group 2). Each group underwent phacoemulsification with implantation of a posterior chamber intraocular lens (IOL) and ultrasound biometry.

Group 1 underwent Scheimpflug keratometry based on pupil size and group 2 had conventional automated keratometry. The Holladay 2 formula was used to evaluate IOL power. Refractive outcomes and keratometry (K) readings were assessed by statistical analysis.

In group 1 the mean K reading and mean absolute refractive error was 43.45 D and 0.480 D, respectively. In group 2 it was 43.51 D and 0.252 D, respectively- meaning the absolute refractive error between the two groups was statistically significant.

Of the 110 eyes studied in group 1, 77 were within ±0.50 D of the intended postoperative refraction, 28 were between ±0.50 D and ±1.00 D, 4 were between ±1.00 D and ±1.50 D, and 1 was between ±1.50 D and ±2.00 D. Group 2 saw 131 eyes within ±0.50 D, 3 were between ±0.50 D and ±1.00 D, and 3 were between ±1.00 D and ±1.50 D. The findings were described as statistically significant between the 2 groups.

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Subscribe Now!

Recent Videos

At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients

Early intervention is crucial for long-term outcomes in paediatric gene therapy

$At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery$

Robert Ang, MD, explains why a small-aperture IOL is "not a niche product"

Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.

ARVO 2025: Ocular and systemic mitochondrial diseases may be key to dementia diagnosis

Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).

ARVO 2025: Alfredo Sadun, MD, PhD, says "later is better" for some LHON interventions

At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.

ARVO 2025: Nitish Mehta, MD, provides real-world insights from aflibercept 8 mg for treatment-naive diabetic macular oedema

ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy

ARVO 2025: Anat Loewenstein, MD, and colleagues on meeting needs of patients with diabetic retinopathy

$At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study$

Sheng Lim, MD, FRCOphth, brings data from the CONCEPT study to the ASCRS meeting